Quick Takeaways
- EdgePoint Investment Group Inc. filed SCHEDULE 13G/A for Twist Bioscience Corp Common stock, $0.00001 par value per share (TWST).
- Disclosed ownership: 8.8%.
- Date of event: 31 Dec 2025.
EdgePoint Investment Group Inc. - 31 Dec 2025 SCHEDULE 13G/A Report for Twist Bioscience Corp Common stock, $0.00001 par value per share (TWST)
- Filing Manager
- EdgePoint Investment Group Inc.
- Reporting Manager
- EdgePoint Investment Group Inc.
- Symbol
- TWST
- Shares outstanding
- 61,113,534 shares
- Disclosed Ownership
- 5,377,991 shares
- Ownership
- 8.8%
- Form type
- SCHEDULE 13G/A
- Filing time
- 17 Feb 2026, 16:21:50 UTC
- Date of event
- 31 Dec 2025
- Previous filing
- 14 Nov 2025
- SEC
- View on sec.gov
Quoteable Key Fact
"EdgePoint Investment Group Inc. disclosed 8.8% ownership in Twist Bioscience Corp Common stock, $0.00001 par value per share (TWST) on 31 Dec 2025."
What Changed
- Previous schedule filing date: 14 Nov 2025.
- Current filing was accepted on 17 Feb 2026, 16:21.
Why This Matters
- This page explains what this Schedule 13D/13G filing tells you before manager-level rows.
- You can verify ownership claims directly against the original SEC filing.
Source Evidence
Backed by Schedule 13D/13G
See Original Filing
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
Reporting Managers (1)
| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| EdgePoint Investment Group Inc. | 8.8% | 5,377,991 | 4,165,651 | 1,212,340 | Sayuri Childs | Sayuri Childs | Chief Compliance Officer |